Biologics at USP Blog

Insights and trends in biologics development and manufacturing

Read blogs
USP_Biologics_1520x960pxl_Blog

Welcome
USP is the logical choice for consistency and reproducibility in reference standards for biologics.

USP’s biologics blog delivers trends and insights impacting the development, manufacture and regulatory approval of biologics and biosimilars. Updated regularly, the blog covers a broad range of topics of interest to anyone working in the field of biopharmaceuticals.

We invite you to subscribe today and receive a regular email summary of our blog posts.

USP Team

Contributor: John Duguid,
Senior Director, Research & Development Vericel Corporation usp-team

Recent Posts

Rapid Microbial Methods: The Need for Speed in Cell and Gene Therapies

July 24, 2018 | USP Team
Contributor: John Duguid,
Senior Director, Research & Development Vericel Corporation

When patients are administered biological treatments created from their own bodies - autologous regenerative medicines - every second counts. Quality and purity can’t be compromised. To ensure microbial contaminants are removed during the manufacturing process, rapid microbial methods are needed for cell therapy, tissue-engineered, and gene therapy products.

Categories